Long-term outcome in children with primary distal renal tubular acidosis

Anurag Bajpai1, Arvind Bagga, Pankaj Hari

  • 1Division of Pediatric Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029, India.

Indian Pediatrics
|May 7, 2005
PubMed

Insights

Early diagnosis and treatment are crucial for children with distal renal tubular acidosis (RTA). Adequate management improves growth outcomes, but complications like short stature and failure to thrive persist in some cases.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Distal renal tubular acidosis (RTA) in children can lead to significant growth impairment and complications.
  • Adequate treatment is essential, but factors influencing long-term outcomes require further evaluation.

Purpose of the Study:

  • To assess complications in children with distal RTA receiving appropriate treatment.
  • To identify factors that influence the development of these complications.

Main Methods:

  • Retrospective review of medical records for 18 children with primary distal RTA followed for at least 2 years.
  • Analysis of growth parameters (height, weight, growth velocity) using standard deviation scores (SDS).
  • Regression analysis to determine factors affecting growth and complication development.

Main Results:

  • All patients presented with short stature and failure to thrive at diagnosis.
  • Growth parameters improved with treatment, but some long-term deficits remained.
  • Nephrocalcinosis was present in 44.4% of patients, associated with higher urine calcium excretion.
  • Initial height SDS was the primary factor influencing height improvement on multivariate analysis.

Conclusions:

  • Early diagnosis and consistent treatment are vital for improving outcomes in pediatric distal RTA.
  • Regular follow-up is necessary to monitor for and manage complications.
  • Further research may elucidate more specific interventions to optimize growth and prevent complications.
Abstract

Related Concept Videos

Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...